Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
Zohreh A Fay
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 14 Dec, 2021
"Remove inverse infobox"
Golden AI
edited on 14 Dec, 2021
Edits made to:
Infobox
(
-48
properties)
Infobox
Patent primary examiner of
US Patent 11166981 Methods and compositions for treating chlorine-gas induced lung injury
US Patent 11168054 Biaromatic compounds, which are vitamin D analogs
US Patent 11173133 Zeaxanthin formulations with additional ocular-active nutrients, for protecting eye health and treating eye disorders
US Patent 7230032 Calcium blockers to treat proliferative vitreoretinopathy
US Patent 7238661 Oral lactoferrin in the treatment of respiratory disorders
US Patent 11179294 Preservative removal from eye drops
US Patent 11179331 Oral soluble film containing sildenafil citrate
US Patent 11179362 Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
US Patent 7402609 Olopatadine formulations for topical administration
US Patent 7429602 Treating conjunctivitis by topically administering an epinastine solution to the conjunctiva
US Patent 7452871 Compositions and methods for treating mammals with modified alginates and modified pectins
US Patent 11185544 Formulations of 4-methyl-5-(pyrazin-2-yl)-3H-l,2-dithiole-3-thione, taste-modified formulations, and methods of making and using same
US Patent 7528172 Compositions and methods for improving recovery after general anesthesia
US Patent 7541024 Low salt forms of polyallylamine
US Patent 7625927 Method of treating glaucoma
US Patent 7648716 Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide
US Patent 7659260 Tamponade compositions and methods for retinal repair
US Patent 7671070 Method of treating ophthalmic infections with moxifloxacin compositions
US Patent 7678389 Treatment of optic and otic inflammation
US Patent 7687069 Time release patch containing phage associated lytic enzymes for treating bacterial infections of the skin
US Patent 7723287 Treatment of the eye with a pharmaceutical composition
US Patent 7732425 Pharmaceutical composition for ophthalmic use
US Patent 7732487 Method for treating a disease or condition responsive to opening of C1C-2 channel
US Patent 7745461 Method of treating dry eye disorders
US Patent 7754706 Superoxide dismutase mimics for the treatment of ocular disorders and diseases
US Patent 7754765 Copper chelators for treating ocular inflammation
US Patent 7754768 Methods and compositions for modulating alpha adrenergic receptor activity
US Patent 7759333 Superoxide dismutase mimics for the treatment of ocular disorders and diseases
US Patent 7763619 Compounds with 5-HT
US Patent 7776907 Methods for the treatment and management of macular degeneration using cyclopropyl-N-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-3-oxoisoindoline-4-yl}carboxamide
US Patent 7776925 Reversing, postponing or preventing the occurrence of GTN tolerance and/or generation of reactive oxygen species from mitochondria
US Patent 7785628 DL-lactide-ε-coprolactone copolymers
US Patent 7789610 Methods for preventing/treating damage to sensory hair cells and cochlear neurons
US Patent 7816399 Medicines and medicinal kits
US Patent 7816407 Agmatine and agmatine analogs in the treatment of epilepsy, seizure, and electroconvulsive disorders
US Patent 7825102 Treatment of dry eye conditions
US Patent 7838557 Concentrated X-ray contrast media can act as universal antigens and can inhibit or prevent allergic reactions
US Patent 7842722 Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision
US Patent 7851504 Enhanced bimatoprost ophthalmic solution
US Patent 7879824 Methods of preventing or treating diseases and conditions using complex carbohydrates
US Patent 7888370 Topical ophthalmic or otic solution formulations containing moxifloxacin hydrochloride and dexamethasone phosphate
US Patent 7888371 Use of triazolopyrimidine derivatives as microbicides
US Patent 7888385 Airway alkalinization as therapy for airway diseases
US Patent 7888389 Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies
US Patent 7897642 Compositions and methods for dry eye syndrome
US Patent 7906498 Cholesterol as an antibiotic for
US Patent 7915312 Physiological method of improving vision
US Patent 7923469 Compositions including vitamin-based surfactants and methods for using same
Edits on 7 Dec, 2021
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7923469 Compositions including vitamin-based surfactants and methods for using same
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7915312 Physiological method of improving vision
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7906498 Cholesterol as an antibiotic for
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7897642 Compositions and methods for dry eye syndrome
Edits on 6 Dec, 2021
Golden AI
edited on 6 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7888385 Airway alkalinization as therapy for airway diseases
Golden AI
edited on 6 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7888389 Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies
Golden AI
edited on 6 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7888370 Topical ophthalmic or otic solution formulations containing moxifloxacin hydrochloride and dexamethasone phosphate
Golden AI
edited on 6 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7888371 Use of triazolopyrimidine derivatives as microbicides
Golden AI
edited on 6 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7879824 Methods of preventing or treating diseases and conditions using complex carbohydrates
Golden AI
edited on 6 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7851504 Enhanced bimatoprost ophthalmic solution
Golden AI
edited on 6 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7842722 Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision
Golden AI
edited on 6 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7838557 Concentrated X-ray contrast media can act as universal antigens and can inhibit or prevent allergic reactions
Golden AI
edited on 6 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7825102 Treatment of dry eye conditions
Golden AI
edited on 6 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7816407 Agmatine and agmatine analogs in the treatment of epilepsy, seizure, and electroconvulsive disorders
Golden AI
edited on 6 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7816399 Medicines and medicinal kits
Edits on 5 Dec, 2021
Golden AI
edited on 5 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7789610 Methods for preventing/treating damage to sensory hair cells and cochlear neurons
Golden AI
edited on 5 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7785628 DL-lactide-ε-coprolactone copolymers
Golden AI
edited on 5 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7776925 Reversing, postponing or preventing the occurrence of GTN tolerance and/or generation of reactive oxygen species from mitochondria
Golden AI
edited on 5 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7776907 Methods for the treatment and management of macular degeneration using cyclopropyl-N-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-3-oxoisoindoline-4-yl}carboxamide
Load more
Find more people like Zohreh A Fay
Use the Golden Query Tool to discover related individuals, professionals, or experts with similar interests, expertise, or connections in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE